U.S., Jan. 15 -- ClinicalTrials.gov registry received information related to the study (NCT07340697) titled 'Evaluate RLS-1496 Topical Cream for Actinic Keratosis' on Jan. 13.
Brief Summary: This clinical trial will assess the safety and tolerability of topical application of RLS-1496 cream to lesions and adjacent skin on the left forearm of adults with actinic keratoses (AK) on the arms. The right forearm will remain untreated as a control. The therapeutic objective of topical treatment with RLS-1496 cream is to clear or decrease the number of AK in the treated area, per lesion counts performed by the Investigator.
The main questions it aims to answer are:
* Is it safe to apply topical RLS-1496 cream to treat AK once daily for 28 days?...